Brain Abscesses Due to Aspergillus nidulans Infection During Induction Chemotherapy for Acute Lymphoblastic Leukemia

Manish Sadarangani1, Melissa Harvey, Allison McDonald

  • 1*Department of Paediatrics, Division of Infectious Diseases ‡Department of Paediatrics, Division of Hematology and Oncology, University of British Columbia and BC Children's Hospital §Child and Family Research Institute, Vancouver, BC, Canada †Department of Paediatrics, University of Oxford, Oxford, UK.

Insights

A young boy with acute lymphoblastic leukemia developed invasive aspergillosis, a rare fungal infection, during chemotherapy. Prompt treatment with antifungal medications led to his complete recovery.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Mycology

Background:

  • Acute lymphoblastic leukemia (ALL) treatment, particularly induction chemotherapy, can increase the risk of invasive fungal infections.
  • Invasive aspergillosis is a serious opportunistic infection, with Aspergillus nidulans being a rare causative agent, especially in immunocompromised children without chronic granulomatous disease.

Observation:

  • A 3-year-old boy undergoing induction chemotherapy for ALL developed cerebral abscesses.
  • Cerebral abscesses were diagnosed as Aspergillus nidulans infection on day 28 of chemotherapy.

Findings:

  • The patient received treatment with voriconazole and caspofungin.
  • Successful treatment resulted in a complete recovery from the invasive aspergillosis.

Implications:

  • This case highlights the potential for rare Aspergillus species like A. nidulans to cause invasive disease in pediatric leukemia patients.
  • Early diagnosis and aggressive antifungal therapy are crucial for managing invasive aspergillosis in immunocompromised children.
  • Further research may be warranted on the incidence and management of rare fungal infections during pediatric leukemia treatment.